Skip to main content
. 2022 Jan 10;11(2):332. doi: 10.3390/jcm11020332

Table 1.

Characteristics of AML patients included in the study.

Data Serum Study Group
Range and Median
(n = 37) 1
Genetic Study Group
Range and Median
(n = 92) 1
age 25–93, med = 62 20–93, med = 61
bone marrow blasts (%) 4–95, med = 68 20–98, med = 65
white blood cell count (G/L) 0.8–510.5, med = 22.7 0.7–510.5, med = 21
haemoglobin (g/dL) 6.0–11.4, med = 8.8 6.1–19.5, med = 9.2
platelets (G/L) 5–393, med = 44.5 2–460, med = 52
lactate dehydrogenase (U/L) 168–2170, med = 446.5 26–2535, med = 369
C-reactive protein (mg/L) 2.3–115.4, med = 36.3 1.1–359, med = 25

1 The serum study group (n = 37) was used for analysis of serum soluble BSG, while the larger genetic study group (n = 92) was used for analyses of BSG and MCT1 genetic polymorphism.